After receiving intense backlash from consumers, lawmakers, and health advocates over the skyrocketing price of emergency allergy treatment EpiPen — the costs increased as much as 600% in just nine years — pharmaceutical giant Mylan plans to cover some of that cost for certain patients. [More]
